top of page

Meeting with the Korean company EDmicBio


Rencontre avec la société coréenne EDmicBio

Meeting with the Korean company EDmicBio

Back in pictures of the meeting with the Korean company @EDmicBio which was held on May 17, 2019 at Cancer Campus in the presence of the CEO Mr Lee Albert and the COO Mr Ha Matt with doctors and researchers from the Gustave Roussy Institute. EDmicBio is developing an in vitro platform that can partially or fully replace animal testing, while shortening the development cycle, reducing costs and improving the overall efficiency of the drug development process. EDmicBio proposes a "3D Organ-on-chip" technology; this technology is based on miniature organ models that can be used in pre-clinical



4 views0 comments

Comments


bottom of page